Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of a novel index combining the prognostic nutritional index and D-dimer levels for gastric cancer after gastrectomy.
Yamamoto M, Omori T, Shinno N, Hara H, Mukai Y, Sugase T, Takeoka T, Kanemura T, Mikamori M, Hasegawa S, Akita H, Haraguchi N, Nishimura J, Wada H, Matsuda C, Yasui M, Miyata H, Ohue M. Yamamoto M, et al. Among authors: shinno n. Oncology. 2023 Dec 30. doi: 10.1159/000533150. Online ahead of print. Oncology. 2023. PMID: 38160660
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma.
Sugase T, Kanemura T, Takeoka T, Matsuura N, Masuike Y, Shinno N, Hara H, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Omori T, Miyata H. Sugase T, et al. Among authors: shinno n. Anticancer Res. 2024 Jan;44(1):185-193. doi: 10.21873/anticanres.16801. Anticancer Res. 2024. PMID: 38159967
Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy.
Sugase T, Kanemura T, Takeoka T, Matsuura N, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: shinno n. Oncology. 2023 Dec 5. doi: 10.1159/000535186. Online ahead of print. Oncology. 2023. PMID: 38052183
Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.
Kanemura T, Takeoka T, Sugase T, Urakawa S, Masuike Y, Shinno N, Hara H, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Omori T, Miyata H. Kanemura T, et al. Among authors: shinno n. Ann Surg Oncol. 2024 Feb;31(2):818-826. doi: 10.1245/s10434-023-14306-5. Epub 2023 Nov 21. Ann Surg Oncol. 2024. PMID: 37989955
Clinicopathological Characteristics and Survival Outcomes in Patients with Advanced Esophageal Squamous Cell Carcinoma Who Were Intraoperatively Diagnosed Non-Curative.
Sugase T, Kanemura T, Takeoka T, Sugimura K, Yamamoto M, Shinno N, Hara H, Omori T, Mukai Y, Mikamori M, Hasegawa S, Haraguchi N, Akita H, Nishimura J, Wada H, Matsuda C, Yasui M, Miyata H. Sugase T, et al. Among authors: shinno n. Oncology. 2024;102(5):339-349. doi: 10.1159/000533772. Epub 2023 Nov 3. Oncology. 2024. PMID: 37926097
Clinical Impact of Enhanced Recovery After Esophagectomy in Patients With Esophageal Cancer.
Sugase T, Kanemura T, Takeoka T, Urakawa S, Sugimura K, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: shinno n. Anticancer Res. 2023 Sep;43(9):4197-4205. doi: 10.21873/anticanres.16611. Anticancer Res. 2023. PMID: 37648293
80 results